Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M MacDonald

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Journal of the American Heart Association|November 20, 2017
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled TrialThomas M MacDonald, Bryan Williams, David J Webb, et al.
Lancet (London, England)|November 12, 2020
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trialIsla S Mackenzie, Ian Ford, George Nuki, et al.
Hypertension (Dallas, Tex. : 1979)|July 30, 2024
<i>UMOD</i> Genotype-Blinded Trial of Ambulatory Blood Pressure Response to TorasemideLinsay McCallum, Stefanie Lip, Alex McConnachie, et al.
Health Technology Assessment (Winchester, England)|March 12, 2021
The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTsEmily Herrett, Elizabeth Williamson, Kieran Brack, et al.
Drug Safety|May 29, 2019
Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350Joan Fortuny, Alicia Gilsenan, Miguel Cainzos-Achirica, et al.
Drug Safety|May 29, 2019
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort StudyAlicia Gilsenan, Joan Fortuny, Miguel Cainzos-Achirica, et al.
American Journal of Hypertension|May 21, 2025
Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive PatientsEirik Olsen, Camilla L Søraas, Roland E Schmieder, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
BMJ (Clinical Research Ed.)|February 25, 2021
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trialsEmily Herrett, Elizabeth Williamson, Kieran Brack, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Journal of the American Heart Association|November 20, 2017
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled TrialThomas M MacDonald, Bryan Williams, David J Webb, et al.
Lancet (London, England)|November 12, 2020
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trialIsla S Mackenzie, Ian Ford, George Nuki, et al.
Hypertension (Dallas, Tex. : 1979)|July 30, 2024
<i>UMOD</i> Genotype-Blinded Trial of Ambulatory Blood Pressure Response to TorasemideLinsay McCallum, Stefanie Lip, Alex McConnachie, et al.
Health Technology Assessment (Winchester, England)|March 12, 2021
The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTsEmily Herrett, Elizabeth Williamson, Kieran Brack, et al.
Drug Safety|May 29, 2019
Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350Joan Fortuny, Alicia Gilsenan, Miguel Cainzos-Achirica, et al.
Drug Safety|May 29, 2019
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort StudyAlicia Gilsenan, Joan Fortuny, Miguel Cainzos-Achirica, et al.
American Journal of Hypertension|May 21, 2025
Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive PatientsEirik Olsen, Camilla L Søraas, Roland E Schmieder, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
BMJ (Clinical Research Ed.)|February 25, 2021
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trialsEmily Herrett, Elizabeth Williamson, Kieran Brack, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Pageof 16